Global Rosuvastatin (CAS 287714-41-4) Market Insights and Forecast to 2028

Q: How big is the rosuvastatin cas 287714414 market?

Rosuvastatin API in this report.Market Analysis and Insights Global Rosuvastatin CAS 287714414 MarketDue to the COVID19 pandemic the global Rosuvastatin CAS 287714414 market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Q: Who are the key players in the rosuvastatin cas 287714414 market?

Some of the key players are Anuh Pharma LTD, Anwita Drugs& Chemicals Pvt Ltd, Aspen Biopharma Labs Pvt Ltd, DSM Sinochem Pharmaceuticals, Jeil Pharmaceutical Co., Ltd, Jubilant Life Sciences Limited, Kores India Limited, Titan Laboratories Pvt Ltd, Others.

Code: QYRE-Auto-6U7387

Report

January 2022

Pages:88

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Anuh Pharma LTD

Anwita Drugs& Chemicals Pvt Ltd

Aspen Biopharma Labs Pvt Ltd

DSM Sinochem Pharmaceuticals

Jeil Pharmaceutical Co., Ltd

Jubilant Life Sciences Limited

Kores India Limited

Titan Laboratories Pvt Ltd

Rosuvastatin API in this report.

Market Analysis and Insights: Global Rosuvastatin (CAS 287714-41-4) Market

Due to the COVID-19 pandemic, the global Rosuvastatin (CAS 287714-41-4) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Purity ≥98% accounting for % of the Rosuvastatin (CAS 287714-41-4) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While 5mg Tablet segment is altered to an % CAGR throughout this forecast period.

China Rosuvastatin (CAS 287714-41-4) market size is valued at US$ million in 2021, while the US and Europe Rosuvastatin (CAS 287714-41-4) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Rosuvastatin (CAS 287714-41-4) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Rosuvastatin (CAS 287714-41-4) include Anuh Pharma LTD, Anwita Drugs & Chemicals Pvt Ltd, Aspen Biopharma Labs Pvt Ltd, DSM Sinochem Pharmaceuticals, Jeil Pharmaceutical Co., Ltd, Jubilant Life Sciences Limited, Kores India Limited and Titan Laboratories Pvt Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

In terms of production side, this report researches the Rosuvastatin (CAS 287714-41-4) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.

In terms of sales side, this report focuses on the sales of Rosuvastatin (CAS 287714-41-4) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.

Global Rosuvastatin (CAS 287714-41-4) Scope and Segment

Rosuvastatin (CAS 287714-41-4) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rosuvastatin (CAS 287714-41-4) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Purity ≥98%

Purity ≥99%

Segment by Application

5mg Tablet

10mg Tablet

20mg Tablet

40mg Tablet

BY COMPANY

Anuh Pharma LTD

Anwita Drugs & Chemicals Pvt Ltd

Aspen Biopharma Labs Pvt Ltd

DSM Sinochem Pharmaceuticals

Jeil Pharmaceutical Co., Ltd

Jubilant Life Sciences Limited

Kores India Limited

Titan Laboratories Pvt Ltd

Production by Region

North America

Europe

China

Japan

Consumption by Region

North America

United States

Canada

Mexico

Europe

Germany

France

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

Anuh Pharma LTD

Anwita Drugs& Chemicals Pvt Ltd

Aspen Biopharma Labs Pvt Ltd

DSM Sinochem Pharmaceuticals

Jeil Pharmaceutical Co., Ltd

Jubilant Life Sciences Limited

Kores India Limited

Titan Laboratories Pvt Ltd

1 Study Coverage

1.1 Rosuvastatin (CAS 287714-41-4) Product Introduction

1.2 Market by Type

1.2.1 Global Rosuvastatin (CAS 287714-41-4) Market Size by Type, 2017 VS 2021 VS 2028

1.2.2 Purity ≥98%

1.2.3 Purity ≥99%

1.3 Market by Application

1.3.1 Global Rosuvastatin (CAS 287714-41-4) Market Size by Application, 2017 VS 2021 VS 2028

1.3.2 5mg Tablet

1.3.3 10mg Tablet

1.3.4 20mg Tablet

1.3.5 40mg Tablet

1.4 Study Objectives

1.5 Years Considered

2 Global Rosuvastatin (CAS 287714-41-4) Production

2.1 Global Rosuvastatin (CAS 287714-41-4) Production Capacity (2017-2028)

2.2 Global Rosuvastatin (CAS 287714-41-4) Production by Region: 2017 VS 2021 VS 2028

2.3 Global Rosuvastatin (CAS 287714-41-4) Production by Region

2.3.1 Global Rosuvastatin (CAS 287714-41-4) Historic Production by Region (2017-2022)

2.3.2 Global Rosuvastatin (CAS 287714-41-4) Forecasted Production by Region (2023-2028)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3 Global Rosuvastatin (CAS 287714-41-4) Sales in Volume & Value Estimates and Forecasts

3.1 Global Rosuvastatin (CAS 287714-41-4) Sales Estimates and Forecasts 2017-2028

3.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Estimates and Forecasts 2017-2028

3.3 Global Rosuvastatin (CAS 287714-41-4) Revenue by Region: 2017 VS 2021 VS 2028

3.4 Global Rosuvastatin (CAS 287714-41-4) Sales by Region

3.4.1 Global Rosuvastatin (CAS 287714-41-4) Sales by Region (2017-2022)

3.4.2 Global Sales Rosuvastatin (CAS 287714-41-4) by Region (2023-2028)

3.5 Global Rosuvastatin (CAS 287714-41-4) Revenue by Region

3.5.1 Global Rosuvastatin (CAS 287714-41-4) Revenue by Region (2017-2022)

3.5.2 Global Rosuvastatin (CAS 287714-41-4) Revenue by Region (2023-2028)

3.6 North America

3.7 Europe

3.8 Asia-Pacific

3.9 Latin America

3.10 Middle East & Africa

4 Competition by Manufactures

4.1 Global Rosuvastatin (CAS 287714-41-4) Production Capacity by Manufacturers

4.2 Global Rosuvastatin (CAS 287714-41-4) Sales by Manufacturers

4.2.1 Global Rosuvastatin (CAS 287714-41-4) Sales by Manufacturers (2017-2022)

4.2.2 Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Manufacturers (2017-2022)

4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Rosuvastatin (CAS 287714-41-4) in 2021

4.3 Global Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers

4.3.1 Global Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers (2017-2022)

4.3.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Manufacturers (2017-2022)

4.3.3 Global Top 10 and Top 5 Companies by Rosuvastatin (CAS 287714-41-4) Revenue in 2021

4.4 Global Rosuvastatin (CAS 287714-41-4) Sales Price by Manufacturers

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Rosuvastatin (CAS 287714-41-4) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5.3 Global Rosuvastatin (CAS 287714-41-4) Manufacturers Geographical Distribution

4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Rosuvastatin (CAS 287714-41-4) Sales by Type

5.1.1 Global Rosuvastatin (CAS 287714-41-4) Historical Sales by Type (2017-2022)

5.1.2 Global Rosuvastatin (CAS 287714-41-4) Forecasted Sales by Type (2023-2028)

5.1.3 Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

5.2 Global Rosuvastatin (CAS 287714-41-4) Revenue by Type

5.2.1 Global Rosuvastatin (CAS 287714-41-4) Historical Revenue by Type (2017-2022)

5.2.2 Global Rosuvastatin (CAS 287714-41-4) Forecasted Revenue by Type (2023-2028)

5.2.3 Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

5.3 Global Rosuvastatin (CAS 287714-41-4) Price by Type

5.3.1 Global Rosuvastatin (CAS 287714-41-4) Price by Type (2017-2022)

5.3.2 Global Rosuvastatin (CAS 287714-41-4) Price Forecast by Type (2023-2028)

6 Market Size by Application

6.1 Global Rosuvastatin (CAS 287714-41-4) Sales by Application

6.1.1 Global Rosuvastatin (CAS 287714-41-4) Historical Sales by Application (2017-2022)

6.1.2 Global Rosuvastatin (CAS 287714-41-4) Forecasted Sales by Application (2023-2028)

6.1.3 Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

6.2 Global Rosuvastatin (CAS 287714-41-4) Revenue by Application

6.2.1 Global Rosuvastatin (CAS 287714-41-4) Historical Revenue by Application (2017-2022)

6.2.2 Global Rosuvastatin (CAS 287714-41-4) Forecasted Revenue by Application (2023-2028)

6.2.3 Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

6.3 Global Rosuvastatin (CAS 287714-41-4) Price by Application

6.3.1 Global Rosuvastatin (CAS 287714-41-4) Price by Application (2017-2022)

6.3.2 Global Rosuvastatin (CAS 287714-41-4) Price Forecast by Application (2023-2028)

7 North America

7.1 North America Rosuvastatin (CAS 287714-41-4) Market Size by Type

7.1.1 North America Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2028)

7.1.2 North America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2028)

7.2 North America Rosuvastatin (CAS 287714-41-4) Market Size by Application

7.2.1 North America Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2028)

7.2.2 North America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2028)

7.3 North America Rosuvastatin (CAS 287714-41-4) Sales by Country

7.3.1 North America Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2028)

7.3.2 North America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2028)

7.3.3 United States

7.3.4 Canada

7.3.5 Mexico

8 Europe

8.1 Europe Rosuvastatin (CAS 287714-41-4) Market Size by Type

8.1.1 Europe Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2028)

8.1.2 Europe Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2028)

8.2 Europe Rosuvastatin (CAS 287714-41-4) Market Size by Application

8.2.1 Europe Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2028)

8.2.2 Europe Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2028)

8.3 Europe Rosuvastatin (CAS 287714-41-4) Sales by Country

8.3.1 Europe Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2028)

8.3.2 Europe Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2028)

8.3.3 Germany

8.3.4 France

8.3.5 UK

8.3.6 Italy

8.3.7 Russia

9 Asia Pacific

9.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Market Size by Type

9.1.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2028)

9.1.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2028)

9.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Market Size by Application

9.2.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2028)

9.2.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2028)

9.3 Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Region

9.3.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Region (2017-2028)

9.3.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Region (2017-2028)

9.3.3 China

9.3.4 Japan

9.3.5 South Korea

9.3.6 India

9.3.7 Australia

9.3.8 China Taiwan

9.3.9 Indonesia

9.3.10 Thailand

9.3.11 Malaysia

10 Latin America

10.1 Latin America Rosuvastatin (CAS 287714-41-4) Market Size by Type

10.1.1 Latin America Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2028)

10.1.2 Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2028)

10.2 Latin America Rosuvastatin (CAS 287714-41-4) Market Size by Application

10.2.1 Latin America Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2028)

10.2.2 Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2028)

10.3 Latin America Rosuvastatin (CAS 287714-41-4) Sales by Country

10.3.1 Latin America Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2028)

10.3.2 Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2028)

10.3.3 Mexico

10.3.4 Brazil

10.3.5 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Market Size by Type

11.1.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2028)

11.1.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2028)

11.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Market Size by Application

11.2.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2028)

11.2.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2028)

11.3 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Country

11.3.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2028)

11.3.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2028)

11.3.3 Turkey

11.3.4 Saudi Arabia

11.3.5 UAE

12 Corporate Profiles

12.1 Anuh Pharma LTD

12.1.1 Anuh Pharma LTD Corporation Information

12.1.2 Anuh Pharma LTD Overview

12.1.3 Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.1.4 Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Anuh Pharma LTD Recent Developments

12.2 Anwita Drugs & Chemicals Pvt Ltd

12.2.1 Anwita Drugs & Chemicals Pvt Ltd Corporation Information

12.2.2 Anwita Drugs & Chemicals Pvt Ltd Overview

12.2.3 Anwita Drugs & Chemicals Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.2.4 Anwita Drugs & Chemicals Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 Anwita Drugs & Chemicals Pvt Ltd Recent Developments

12.3 Aspen Biopharma Labs Pvt Ltd

12.3.1 Aspen Biopharma Labs Pvt Ltd Corporation Information

12.3.2 Aspen Biopharma Labs Pvt Ltd Overview

12.3.3 Aspen Biopharma Labs Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.3.4 Aspen Biopharma Labs Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Aspen Biopharma Labs Pvt Ltd Recent Developments

12.4 DSM Sinochem Pharmaceuticals

12.4.1 DSM Sinochem Pharmaceuticals Corporation Information

12.4.2 DSM Sinochem Pharmaceuticals Overview

12.4.3 DSM Sinochem Pharmaceuticals Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.4.4 DSM Sinochem Pharmaceuticals Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 DSM Sinochem Pharmaceuticals Recent Developments

12.5 Jeil Pharmaceutical Co., Ltd

12.5.1 Jeil Pharmaceutical Co., Ltd Corporation Information

12.5.2 Jeil Pharmaceutical Co., Ltd Overview

12.5.3 Jeil Pharmaceutical Co., Ltd Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.5.4 Jeil Pharmaceutical Co., Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Jeil Pharmaceutical Co., Ltd Recent Developments

12.6 Jubilant Life Sciences Limited

12.6.1 Jubilant Life Sciences Limited Corporation Information

12.6.2 Jubilant Life Sciences Limited Overview

12.6.3 Jubilant Life Sciences Limited Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.6.4 Jubilant Life Sciences Limited Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Jubilant Life Sciences Limited Recent Developments

12.7 Kores India Limited

12.7.1 Kores India Limited Corporation Information

12.7.2 Kores India Limited Overview

12.7.3 Kores India Limited Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.7.4 Kores India Limited Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Kores India Limited Recent Developments

12.8 Titan Laboratories Pvt Ltd

12.8.1 Titan Laboratories Pvt Ltd Corporation Information

12.8.2 Titan Laboratories Pvt Ltd Overview

12.8.3 Titan Laboratories Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales, Price, Revenue and Gross Margin (2017-2022)

12.8.4 Titan Laboratories Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Titan Laboratories Pvt Ltd Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Rosuvastatin (CAS 287714-41-4) Industry Chain Analysis

13.2 Rosuvastatin (CAS 287714-41-4) Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Rosuvastatin (CAS 287714-41-4) Production Mode & Process

13.4 Rosuvastatin (CAS 287714-41-4) Sales and Marketing

13.4.1 Rosuvastatin (CAS 287714-41-4) Sales Channels

13.4.2 Rosuvastatin (CAS 287714-41-4) Distributors

13.5 Rosuvastatin (CAS 287714-41-4) Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14.1 Rosuvastatin (CAS 287714-41-4) Industry Trends

14.2 Rosuvastatin (CAS 287714-41-4) Market Drivers

14.3 Rosuvastatin (CAS 287714-41-4) Market Challenges

14.4 Rosuvastatin (CAS 287714-41-4) Market Restraints

15 Key Finding in The Global Rosuvastatin (CAS 287714-41-4) Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

FEATURED COMPANIES

Anuh Pharma LTD

Anwita Drugs& Chemicals Pvt Ltd

Aspen Biopharma Labs Pvt Ltd

DSM Sinochem Pharmaceuticals

Jeil Pharmaceutical Co., Ltd

Jubilant Life Sciences Limited

Kores India Limited

Titan Laboratories Pvt Ltd

List of Tables

Table 1. Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Purity ≥98%

Table 3. Major Manufacturers of Purity ≥99%

Table 4. Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)

Table 5. Global Rosuvastatin (CAS 287714-41-4) Production by Region: 2017 VS 2021 VS 2028 (MT)

Table 6. Global Rosuvastatin (CAS 287714-41-4) Production by Region (2017-2022) & (MT)

Table 7. Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Region (2017-2022)

Table 8. Global Rosuvastatin (CAS 287714-41-4) Production by Region (2023-2028) & (MT)

Table 9. Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Region (2023-2028)

Table 10. Global Rosuvastatin (CAS 287714-41-4) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 11. Global Rosuvastatin (CAS 287714-41-4) Sales by Region (2017-2022) & (MT)

Table 12. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Region (2017-2022)

Table 13. Global Rosuvastatin (CAS 287714-41-4) Sales by Region (2023-2028) & (MT)

Table 14. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Region (2023-2028)

Table 15. Global Rosuvastatin (CAS 287714-41-4) Revenue by Region (2017-2022) & (US$ Million)

Table 16. Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Region (2017-2022)

Table 17. Global Rosuvastatin (CAS 287714-41-4) Revenue by Region (2023-2028) & (US$ Million)

Table 18. Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Region (2023-2028)

Table 19. Global Rosuvastatin (CAS 287714-41-4) Production Capacity by Manufacturers (2017-2022) & (MT)

Table 20. Global Rosuvastatin (CAS 287714-41-4) Capacity Market Share by Manufacturers (2017-2022)

Table 21. Global Rosuvastatin (CAS 287714-41-4) Sales by Manufacturers (2017-2022) & (MT)

Table 22. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Manufacturers (2017-2022)

Table 23. Global Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 24. Global Rosuvastatin (CAS 287714-41-4) Revenue Share by Manufacturers (2017-2022)

Table 25. Rosuvastatin (CAS 287714-41-4) Price by Manufacturers 2017-2022 (USD/MT)

Table 26. Global Rosuvastatin (CAS 287714-41-4) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Rosuvastatin (CAS 287714-41-4) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin (CAS 287714-41-4) as of 2021)

Table 28. Rosuvastatin (CAS 287714-41-4) Manufacturing Base Distribution and Headquarters

Table 29. Manufacturers Rosuvastatin (CAS 287714-41-4) Product Offered

Table 30. Date of Manufacturers Enter into Rosuvastatin (CAS 287714-41-4) Market

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 33. Global Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 34. Global Rosuvastatin (CAS 287714-41-4) Sales Share by Type (2017-2022)

Table 35. Global Rosuvastatin (CAS 287714-41-4) Sales Share by Type (2023-2028)

Table 36. Global Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 37. Global Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 38. Global Rosuvastatin (CAS 287714-41-4) Revenue Share by Type (2017-2022)

Table 39. Global Rosuvastatin (CAS 287714-41-4) Revenue Share by Type (2023-2028)

Table 40. Rosuvastatin (CAS 287714-41-4) Price by Type (2017-2022) & (USD/MT)

Table 41. Global Rosuvastatin (CAS 287714-41-4) Price Forecast by Type (2023-2028) & (USD/MT)

Table 42. Global Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 43. Global Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 44. Global Rosuvastatin (CAS 287714-41-4) Sales Share by Application (2017-2022)

Table 45. Global Rosuvastatin (CAS 287714-41-4) Sales Share by Application (2023-2028)

Table 46. Global Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 47. Global Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 48. Global Rosuvastatin (CAS 287714-41-4) Revenue Share by Application (2017-2022)

Table 49. Global Rosuvastatin (CAS 287714-41-4) Revenue Share by Application (2023-2028)

Table 50. Rosuvastatin (CAS 287714-41-4) Price by Application (2017-2022) & (USD/MT)

Table 51. Global Rosuvastatin (CAS 287714-41-4) Price Forecast by Application (2023-2028) & (USD/MT)

Table 52. North America Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 53. North America Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 54. North America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 55. North America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 56. North America Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 57. North America Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 58. North America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 59. North America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 60. North America Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2022) & (MT)

Table 61. North America Rosuvastatin (CAS 287714-41-4) Sales by Country (2023-2028) & (MT)

Table 62. North America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2022) & (US$ Million)

Table 63. North America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2023-2028) & (US$ Million)

Table 64. Europe Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 65. Europe Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 66. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 67. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 68. Europe Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 69. Europe Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 70. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 71. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 72. Europe Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2022) & (MT)

Table 73. Europe Rosuvastatin (CAS 287714-41-4) Sales by Country (2023-2028) & (MT)

Table 74. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2022) & (US$ Million)

Table 75. Europe Rosuvastatin (CAS 287714-41-4) Revenue by Country (2023-2028) & (US$ Million)

Table 76. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 77. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 78. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 79. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 80. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 81. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 82. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 83. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 84. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Region (2017-2022) & (MT)

Table 85. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales by Region (2023-2028) & (MT)

Table 86. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Region (2017-2022) & (US$ Million)

Table 87. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue by Region (2023-2028) & (US$ Million)

Table 88. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 89. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 90. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 91. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 92. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 93. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 94. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 95. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 96. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2022) & (MT)

Table 97. Latin America Rosuvastatin (CAS 287714-41-4) Sales by Country (2023-2028) & (MT)

Table 98. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2022) & (US$ Million)

Table 99. Latin America Rosuvastatin (CAS 287714-41-4) Revenue by Country (2023-2028) & (US$ Million)

Table 100. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Type (2017-2022) & (MT)

Table 101. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Type (2023-2028) & (MT)

Table 102. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Type (2017-2022) & (US$ Million)

Table 103. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Type (2023-2028) & (US$ Million)

Table 104. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Application (2017-2022) & (MT)

Table 105. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Application (2023-2028) & (MT)

Table 106. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Application (2017-2022) & (US$ Million)

Table 107. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Application (2023-2028) & (US$ Million)

Table 108. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Country (2017-2022) & (MT)

Table 109. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales by Country (2023-2028) & (MT)

Table 110. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Country (2017-2022) & (US$ Million)

Table 111. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue by Country (2023-2028) & (US$ Million)

Table 112. Anuh Pharma LTD Corporation Information

Table 113. Anuh Pharma LTD Description and Major Businesses

Table 114. Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 115. Anuh Pharma LTD Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Anuh Pharma LTD Recent Development

Table 117. Anwita Drugs & Chemicals Pvt Ltd Corporation Information

Table 118. Anwita Drugs & Chemicals Pvt Ltd Description and Major Businesses

Table 119. Anwita Drugs & Chemicals Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 120. Anwita Drugs & Chemicals Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Anwita Drugs & Chemicals Pvt Ltd Recent Development

Table 122. Aspen Biopharma Labs Pvt Ltd Corporation Information

Table 123. Aspen Biopharma Labs Pvt Ltd Description and Major Businesses

Table 124. Aspen Biopharma Labs Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 125. Aspen Biopharma Labs Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Aspen Biopharma Labs Pvt Ltd Recent Development

Table 127. DSM Sinochem Pharmaceuticals Corporation Information

Table 128. DSM Sinochem Pharmaceuticals Description and Major Businesses

Table 129. DSM Sinochem Pharmaceuticals Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 130. DSM Sinochem Pharmaceuticals Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. DSM Sinochem Pharmaceuticals Recent Development

Table 132. Jeil Pharmaceutical Co., Ltd Corporation Information

Table 133. Jeil Pharmaceutical Co., Ltd Description and Major Businesses

Table 134. Jeil Pharmaceutical Co., Ltd Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 135. Jeil Pharmaceutical Co., Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Jeil Pharmaceutical Co., Ltd Recent Development

Table 137. Jubilant Life Sciences Limited Corporation Information

Table 138. Jubilant Life Sciences Limited Description and Major Businesses

Table 139. Jubilant Life Sciences Limited Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 140. Jubilant Life Sciences Limited Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Jubilant Life Sciences Limited Recent Development

Table 142. Kores India Limited Corporation Information

Table 143. Kores India Limited Description and Major Businesses

Table 144. Kores India Limited Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 145. Kores India Limited Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Kores India Limited Recent Development

Table 147. Titan Laboratories Pvt Ltd Corporation Information

Table 148. Titan Laboratories Pvt Ltd Description and Major Businesses

Table 149. Titan Laboratories Pvt Ltd Rosuvastatin (CAS 287714-41-4) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 150. Titan Laboratories Pvt Ltd Rosuvastatin (CAS 287714-41-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Titan Laboratories Pvt Ltd Recent Development

Table 152. Key Raw Materials Lists

Table 153. Raw Materials Key Suppliers Lists

Table 154. Rosuvastatin (CAS 287714-41-4) Distributors List

Table 155. Rosuvastatin (CAS 287714-41-4) Customers List

Table 156. Rosuvastatin (CAS 287714-41-4) Market Trends

Table 157. Rosuvastatin (CAS 287714-41-4) Market Drivers

Table 158. Rosuvastatin (CAS 287714-41-4) Market Challenges

Table 159. Rosuvastatin (CAS 287714-41-4) Market Restraints

Table 160. Research Programs/Design for This Report

Table 161. Key Data Information from Secondary Sources

Table 162. Key Data Information from Primary Sources

List of Figures

Figure 1. Rosuvastatin (CAS 287714-41-4) Product Picture

Figure 2. Global Rosuvastatin (CAS 287714-41-4) Market Share by Type in 2021 & 2028

Figure 3. Purity ≥98% Product Picture

Figure 4. Purity ≥99% Product Picture

Figure 5. Global Rosuvastatin (CAS 287714-41-4) Market Share by Application in 2021 & 2028

Figure 6. 5mg Tablet

Figure 7. 10mg Tablet

Figure 8. 20mg Tablet

Figure 9. 40mg Tablet

Figure 10. Rosuvastatin (CAS 287714-41-4) Report Years Considered

Figure 11. Global Rosuvastatin (CAS 287714-41-4) Capacity, Production and Utilization (2017-2028) & (MT)

Figure 12. Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Region in Percentage: 2021 Versus 2028

Figure 13. Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Region (2017-2022)

Figure 14. Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Region (2023-2028)

Figure 15. Rosuvastatin (CAS 287714-41-4) Production Growth Rate in North America (2017-2028) & (MT)

Figure 16. Rosuvastatin (CAS 287714-41-4) Production Growth Rate in Europe (2017-2028) & (MT)

Figure 17. Rosuvastatin (CAS 287714-41-4) Production Growth Rate in China (2017-2028) & (MT)

Figure 18. Rosuvastatin (CAS 287714-41-4) Production Growth Rate in Japan (2017-2028) & (MT)

Figure 19. Global Rosuvastatin (CAS 287714-41-4) Sales 2017-2028 (MT)

Figure 20. Global Rosuvastatin (CAS 287714-41-4) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 21. Global Rosuvastatin (CAS 287714-41-4) Revenue 2017-2028 (US$ Million)

Figure 22. Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 23. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Region (2017-2022)

Figure 24. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Region (2023-2028)

Figure 25. North America Rosuvastatin (CAS 287714-41-4) Sales YoY (2017-2028) & (MT)

Figure 26. North America Rosuvastatin (CAS 287714-41-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 27. Europe Rosuvastatin (CAS 287714-41-4) Sales YoY (2017-2028) & (MT)

Figure 28. Europe Rosuvastatin (CAS 287714-41-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 29. Asia-Pacific Rosuvastatin (CAS 287714-41-4) Sales YoY (2017-2028) & (MT)

Figure 30. Asia-Pacific Rosuvastatin (CAS 287714-41-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 31. Latin America Rosuvastatin (CAS 287714-41-4) Sales YoY (2017-2028) & (MT)

Figure 32. Latin America Rosuvastatin (CAS 287714-41-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 33. Middle East & Africa Rosuvastatin (CAS 287714-41-4) Sales YoY (2017-2028) & (MT)

Figure 34. Middle East & Africa Rosuvastatin (CAS 287714-41-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 35. The Rosuvastatin (CAS 287714-41-4) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 36. The Top 5 and 10 Largest Manufacturers of Rosuvastatin (CAS 287714-41-4) in the World: Market Share by Rosuvastatin (CAS 287714-41-4) Revenue in 2021

Figure 37. Rosuvastatin (CAS 287714-41-4) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 38. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 39. Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 40. Global Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 41. Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 42. North America Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 43. North America Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 44. North America Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 45. North America Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 46. North America Rosuvastatin (CAS 287714-41-4) Sales Share by Country (2017-2028)

Figure 47. North America Rosuvastatin (CAS 287714-41-4) Revenue Share by Country (2017-2028)

Figure 48. United States Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 49. Canada Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 50. Mexico Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 51. Europe Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 52. Europe Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 53. Europe Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 54. Europe Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 55. Europe Rosuvastatin (CAS 287714-41-4) Sales Share by Country (2017-2028)

Figure 56. Europe Rosuvastatin (CAS 287714-41-4) Revenue Share by Country (2017-2028)

Figure 57. Germany Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 58. France Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 59. UK Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 60. Italy Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 61. Russia Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 62. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 63. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 64. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 65. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 66. Asia Pacific Rosuvastatin (CAS 287714-41-4) Sales Share by Region (2017-2028)

Figure 67. Asia Pacific Rosuvastatin (CAS 287714-41-4) Revenue Share by Region (2017-2028)

Figure 68. China Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 69. Japan Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 70. South Korea Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 71. India Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 72. Australia Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 73. China Taiwan Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 74. Indonesia Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 75. Thailand Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 76. Malaysia Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 77. Latin America Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 78. Latin America Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 79. Latin America Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 80. Latin America Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 81. Latin America Rosuvastatin (CAS 287714-41-4) Sales Share by Country (2017-2028)

Figure 82. Latin America Rosuvastatin (CAS 287714-41-4) Revenue Share by Country (2017-2028)

Figure 83. Mexico Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 84. Brazil Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 85. Argentina Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 86. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales Market Share by Type (2017-2028)

Figure 87. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Type (2017-2028)

Figure 88. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales Market Share by Application (2017-2028)

Figure 89. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Application (2017-2028)

Figure 90. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Sales Share by Country (2017-2028)

Figure 91. Middle East and Africa Rosuvastatin (CAS 287714-41-4) Revenue Share by Country (2017-2028)

Figure 92. Turkey Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 93. Saudi Arabia Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 94. UAE Rosuvastatin (CAS 287714-41-4) Revenue (2017-2028) & (US$ Million)

Figure 95. Rosuvastatin (CAS 287714-41-4) Value Chain

Figure 96. Rosuvastatin (CAS 287714-41-4) Production Process

Figure 97. Channels of Distribution

Figure 98. Distributors Profiles

Figure 99. Bottom-up and Top-down Approaches for This Report

Figure 100. Data Triangulation

Figure 101. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rosuvastatin (CAS 287714-41-4) Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-6U7387

Global Rosuvastatin (CAS 287714-41-4) Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

Production by Region

Consumption by Region

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions